Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial - Quiz - MDSpire

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

  • By

  • Y. J. L. Bodar

  • B. H. E. Jansen

  • J. P. van der Voorn

  • G. J. C. Zwezerijnen

  • D. Meijer

  • J. A. Nieuwenhuijzen

  • R. Boellaard

  • N. H. Hendrikse

  • O. S. Hoekstra

  • R. J. A. van Moorselaar

  • D. E. Oprea-Lager

  • A. N. Vis

  • October 20, 2020

  • 0 min

Share

Original Source(s)

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

  • by Y. J. L. Bodar, B. H. E. Jansen, J. P. van der Voorn, G. J. C. Zwezerijnen, D. Meijer, J. A. Nieuwenhuijzen, R. Boellaard, N. H. Hendrikse, O. S. Hoekstra, R. J. A. van Moorselaar, D. E. Oprea-Lager, A. N. Vis

  • October 20, 2020

Related Content

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging

99mTc-HDP bone scintigraphy and 18F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer

Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study